Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Bronchiolitis Obliterans
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
15
Start Date:
January 18, 2021
A Phase I Study to Assess Safety of Selective JAK 1 Inhibitor, Itacitinib, in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplant (HCT)
Clinical Trial
Status:
Not yet recruiting
Participants:
2000
Start Date:
January 2021
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Search for trials
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Diagnostic Test
Participants:
20
Start Date:
December 2020
Utility of a Novel Imaging Algorithm (4DX) for the Diagnosis of Constrictive Bronchiolitis
Clinical Trial
Status:
Recruiting
Participants:
15
Start Date:
October 20, 2020
Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children
Clinical Trial
Status:
Recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug
Participants:
45
Start Date:
September 9, 2020
Imaging and Understanding Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplantation With Hyperpolarized 129Xenon MR Lung Imaging
Clinical Trial
Status:
Recruiting
Intervention Type:
Procedure, Other
Participants:
26
Start Date:
August 27, 2020
Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome
Clinical Trial
Status:
Recruiting
Intervention Type:
Diagnostic Test
Participants:
100
Start Date:
August 7, 2020
Screening Microorganism of Cryptogenic Mechanical Pneumonia Through NGS to Lung Tissue Fluid
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
30
Start Date:
June 30, 2020
A Randomized, Open-label,Controlled Phase II b Study to Demonstrate Efficacy and Safety of Sirolimus Chronic Rejection After Lung Transplant
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Other
Participants:
14
Start Date:
March 15, 2020
Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans
Clinical Trial
Status:
Enrolling by invitation
Phase:
Phase 3
Intervention Type:
Drug
Participants:
220
Start Date:
March 3, 2020
A Phase III, Multicenter Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosprine A (L-CsA) Inhalation Solution Delivered Via the PARI Investigational eFlow® Device Plus Standard of Care in the Treatment of Bronchiolitis Obliterans Syndrome in Patients Post Single or Double Lung Transplantation
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
24
Start Date:
February 11, 2020
A Phase IIa Multi-Center, Randomized, Single-Blind Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Device
Participants:
20
Start Date:
February 6, 2020
Study of Pulmonary MRI for the Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Stem Cell Transplantation
Showing 1-12 of 28
Next